Literature DB >> 7386283

Thromboxane A2 receptor antagonism selectively reverses platelet aggregation.

G C Le Breton, D L Venton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7386283

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Res        ISSN： 0361-5952


× No keyword cloud information.
  4 in total

1.  Disaggregation and reaggregation of 'irreversibly' aggregated platelets: a method for more complete evaluation of anti-platelet drugs.

Authors:  G H Rao; J G White
Journal:  Agents Actions       Date:  1985-07

2.  Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.

Authors:  D J Fitzgerald; J Doran; E Jackson; G A FitzGerald
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

3.  The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels.

Authors:  Subhashini Srinivasan; Fozia Mir; Jin-Sheng Huang; Fadi T Khasawneh; Stephen C-T Lam; Guy C Le Breton
Journal:  J Biol Chem       Date:  2009-04-03       Impact factor: 5.157

4.  Tissue plasminogen activator promotes platelet disaggregation in plasma.

Authors:  J Loscalzo; D E Vaughan
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.